Cure My Disease

Don't miss your cure!

 Log in / Sign up

TENS device shows promise for instant neck pain relief

NCT ID NCT07244861

Symptom relief Sponsor: Erzurum Technical University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only This study
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether a 20-minute TENS session can quickly reduce muscle stiffness and pain in people with chronic neck pain. Twenty-four adults will receive either real TENS or a sham device. Researchers measure changes right before and after treatment using a device that checks muscle stiffness and a pain scale.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Transcutaneous Electrical Nerve Stimulation (TENS) device
What this could lead to
If it works, this could show that a short TENS session provides quick relief for neck stiffness and pain, offering a drug-free option for managing symptoms.
What could go wrong
This is a very small, early-stage trial with only 24 people, testing just one session. Results may not apply to long-term use or to everyone with neck pain.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 24 people

The number the study aims to enrol. It can still change while the study runs.

Started

Sep 2025

Expected to finish

Dec 2025

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 50 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age 18-50 years. Neck pain VAS ≥ 3/10 at screening and on test day. Clinical diagnosis of chronic or mechanical neck pain (≥6 weeks). Able to understand study procedures and provide written informed consent. Willing to refrain from analgesics/muscle relaxants and vigorous neck/shoulder exercise for 24 hours before testing. Exclusion Criteria: * Cervical radiculopathy or neurological signs (myotomal weakness, dermatomal sensory loss, reflex changes). Recent invasive procedures to the neck/shoulder (e.g., surgery, injections, radiofrequency/neurotomy) within 6 weeks. Pacemaker/implantable cardioverter, or other active implanted electronic device. Pregnancy or planning pregnancy. Skin conditions at electrode sites (open wounds, infection, severe dermatitis) or known allergy to electrode adhesive/gel. History of epilepsy or unexplained syncope. Acute neck trauma (\<6 weeks) or red flags (fracture, malignancy, infection, inflammatory rheumatic disease). Systemic disorders likely to affect outcomes (e.g., uncontrolled diabetes with neuropathy, severe cardiovascular disease, fibromyalgia with widespread pain). Ongoing electrotherapy to the neck region or botulinum toxin injections to cervical muscles within 3 months. Inability to comply with procedures (e.g., severe communication/cognitive impairment), or insufficient proficiency in Turkish to complete measures.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Chronic neck pain are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Neck Pain

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Chronic neck pain Muscle stiffness Neck pain Transcutaneous electrical nerve stimulation

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    The full official record for this study. This one lists no contact details, but it is the first place any would appear.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Erzurum Technical University Faculty of Health Sciences

    Erzurum, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.